Computed Tomographic Imaging in Connective Tissue Diseases

Abstract

Pulmonary disease represents a significant extra-articular manifestation in the majority of connective tissue diseases (CTDs). The identification, classification, and staging of pulmonary involvement are centrally important to the management of patients, aiding the prognostication of disease behavior and treatment decisions. We present a review of the high-resolution computed tomographic pulmonary features of CTD in the lung and their significance to the reporting radiologist.

Keywords

HRCT - connective tissue disease - fibrosis

• References

• 1 Mikuls TR, Payne JB, Deane KD, Thiele GM. Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: the spark that lights the fire in rheumatoid arthritis?. J Allergy Clin Immunol 2016; 137 (01) 28-34
• 2 Sokka T, Kautiainen H, Toloza S. , et al; QUEST-RA Group. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007; 66 (11) 1491-1496
• 3 Hyldgaard C. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival. Dan Med J 2015; 62 (04) B5069
• 4 Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology 1994; 193 (02) 375-382
• 5 Tanaka N, Kim JS, Newell JD. , et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232 (01) 81-91
• 6 Allain J, Saraux A, Guedes C, Valls I, Devauchelle V, Le Goff P. Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis. Rev Rhum Engl Ed 1997; 64 (10) 531-537
• 7 Aronoff A, Bywaters EG, Fearnley GR. Lung lesions in rheumatoid arthritis. BMJ 1955; 2 (4933): 228-232
• 8 Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 1968; 47 (06) 501-520
• 9 Brazeau-Lamontagne L, Charlin B, Levesque R-Y, Lussier A. Cricoarytenoiditis: CT assessment in rheumatoid arthritis. Radiology 1986; 158 (02) 463-466
• 10 Berjawi G, Uthman I, Mahfoud L. , et al. Cricothyroid joint abnormalities in patients with rheumatoid arthritis. J Voice 2010; 24 (06) 732-737
• 11 Hansell DM. HRCT of obliterative bronchiolitis and other small airways diseases. Semin Roentgenol 2001; 36 (01) 51-65
• 12 Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998; 157 (5 Pt 1): 1658-1665
• 13 Hansell DM, Rubens MB, Padley SP, Wells AU. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 1997; 203 (03) 721-726
• 14 Bruguera-Àvila N, Sánchez-Martínez E, Garcia-Olivé I, Pérez-Ochoa JF, Martínez-Barenys C, Ruiz-Manzano J. Obliterating bronchiolitis in a patient treated with d-penicillamine [in Spanish]. Arch Bronconeumol 2013; 49 (09) 411-412
• 15 Wilsher M, Voight L, Milne D. , et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 2012; 106 (10) 1441-1446
• 16 Tokura S, Okuma T, Akira M, Arai T, Inoue Y, Kitaichi M. Utility of expiratory thin-section CT for fibrotic interstitial pneumonia. Acta Radiol 2014; 55 (09) 1050-1055
• 17 Park WH, Kim SS, Shim SC. , et al. Visual assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: is it associated with airway abnormalities?. Hai 2016; 194 (01) 97-105
• 18 Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JDA, Müller NL. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999; 212 (03) 637-642
• 19 Zhang Y, Li H, Wu N, Dong X, Zheng Y. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 2017; 36 (04) 817-823
• 20 Kelly CA, Saravanan V, Nisar M. , et al; British Rheumatoid Interstitial Lung (BRILL) Network. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. Rheumatology (Oxford) 2014; 53 (09) 1676-1682
• 21 Nurmi HM, Kettunen H-P, Suoranta S-K. , et al. Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. Respir Med 2018; 134: 24-30
• 22 Raghu G, Remy-Jardin M, Myers JL. , et al; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198 (05) e44-e68
• 23 Jacob J, Hirani N, van Moorsel CHM. , et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J 2019; 53 (01) 1800869
• 24 Solomon JJ, Ryu JH, Tazelaar HD. , et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med 2013; 107 (08) 1247-1252
• 25 Tanaka N, Kunihiro Y, Kubo M. , et al. HRCT findings of collagen vascular disease-related interstitial pneumonia (CVD-IP): a comparative study among individual underlying diseases. Clin Radiol 2018; 73 (09) 833.e1-833.e10
• 26 Tsuchiya Y, Takayanagi N, Sugiura H. , et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37 (06) 1411-1417
• 27 Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953; 8 (01) 29-37
• 28 Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Rheumatoid pneumoconiosis (Caplan's syndrome). Eur J Intern Med 2010; 21 (03) 168-172
• 29 Mack U, Schmidt K, Heine M. [Fatal diffuse alveolar damage after gold medication]. Pneumologie 1994; 48 (05) 405-408
• 30 Parambil JG, Myers JL, Ryu JH. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 2006; 130 (02) 553-558
• 31 Hozumi H, Nakamura Y, Johkoh T. , et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 2013; 3 (09) e003132
• 32 Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Acute exacerbations of interstitial lung diseases. Curr Opin Pulm Med 2010; 16 (05) 480-486
• 33 Lloyd CR, Walsh SLF, Hansell DM. High-resolution CT of complications of idiopathic fibrotic lung disease. Br J Radiol 2011; 84 (1003): 581-592
• 34 Cottin V, Nunes H, Mouthon L. , et al; Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63 (01) 295-304
• 35 Jacob J, Song JW, Yoon HY. , et al. Prevalence and effects of emphysema in never-smokers with rheumatoid arthritis interstitial lung disease. EBioMedicine 2018; 28: 303-310
• 36 Koslow M, Young JR, Yi ES. , et al. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol 2019; 29: 1684-1692
• 37 Kobayashi T, Satoh K, Ohkawa M, Satoh A. Multiple rheumatoid nodules with rapid thin-walled cavity formation producing pneumothorax. J Thorac Imaging 2005; 20 (01) 47-49
• 38 Das CJ, Seith A, Debnath J, Kumar U, Sharma SG, Aron M. Aspergillus colonisation of pulmonary rheumatoid nodules: a rare cause of ‘bull's eye’ appearance. Indian J Chest Dis Allied Sci 2009; 51 (01) 41-43
• 39 Young A, Koduri G, Batley M. , et al; Early Rheumatoid Arthritis Study (ERAS) group. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2007; 46 (02) 350-357
• 40 Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 2003; 30 (05) 958-965
• 41 Assayag D, Elicker BM, Urbania TH. , et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 2014; 270 (02) 583-588
• 42 Kim EJ, Elicker BM, Maldonado F. , et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35 (06) 1322-1328
• 43 Park I-N, Kim DS, Shim TS. , et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132 (01) 214-220
• 44 Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis. Chest 2016; 149 (05) 1205-1214
• 45 Matsumoto T, Iwano S, Takahashi N. , et al. Association between chest computed tomography findings and respiratory adverse events in rheumatoid arthritis patients undergoing long-term biological therapy. Int J Rheum Dis 2018 in press
• 46 Lawrence RC, Helmick CG, Arnett FC. , et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41 (05) 778-799
• 47 Jacobsen S, Petersen J, Ullman S. , et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17 (06) 468-477.
• 48 Kim JS, Kim D, Joo YB. , et al. Factors associated with development and mortality of pulmonary hypertension in systemic lupus erythematosus patients. Lupus 2018; 27 (11) 1769-1777
• 49 Kim JS, Lee KS, Koh EM, Kim SY, Chung MP, Han J. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000; 24 (01) 9-18
• 50 Wan SA, Teh CL, Jobli AT. Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution. Lupus 2016; 25 (13) 1485-1490
• 51 Matthay RA, Schwarz MI, Petty TL. , et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975; 54 (05) 397-409
• 52 Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 2000; 118 (04) 1083-1090
• 53 Cheah FK, Sheppard MN, Hansell DM. Computed tomography of diffuse pulmonary haemorrhage with pathological correlation. Clin Radiol 1993; 48 (02) 89-93
• 54 Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996; 166 (02) 301-307
• 55 Bankier AA, Kiener HP, Wiesmayr MN. , et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995; 196 (03) 835-840
• 56 Saito Y, Terada M, Takada T. , et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002; 26 (03) 349-357
• 57 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165 (02) 277-304
• 58 Tansey D, Wells AU, Colby TV. , et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44 (06) 585-596
• 59 Takada H, Saito Y, Nomura A. , et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus. Pediatr Pulmonol 2005; 40 (03) 257-260
• 60 Yood RA, Steigman DM, Gill LR. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus 1995; 4 (02) 161-163
• 61 Esmaeilbeigi F, Juvet S, Hwang D, Mittoo S. Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus. Can Respir J 2012; 19 (01) 50-52
• 62 Medlin JL, Hansen KE, McCoy SS, Bartels CM. Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis. Semin Arthritis Rheum 2018; 48 (02) 198-204
• 63 Alamoudi OSB, Attar SM. Pulmonary manifestations in systemic lupus erythematosus: association with disease activity. Respirology 2015; 20 (03) 474-480
• 64 Li M, Wang Q, Zhao J. , et al; CSTAR co-authors. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 2014; 23 (10) 1085-1091
• 65 Prabu A, Patel K, Yee C-S. , et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 2009; 48 (12) 1506-1511
• 66 Johnson SR, Granton JT. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev 2011; 20 (122) 277-286
• 67 Yurkovich M, Vostretsova K, Chen W, Aviña-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014; 66 (04) 608-616
• 68 Min HK, Lee JH, Jung SM. , et al. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. Korean J Intern Med (Korean Assoc Intern Med) 2015; 30 (02) 232-241
• 69 Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978; 57 (06) 545-560
• 70 Benham H, Garske L, Vecchio P, Eckert BW. Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J Clin Rheumatol 2010; 16 (02) 68-70
• 71 Mayes MD, Lacey Jr JV, Beebe-Dimmer J. , et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48 (08) 2246-2255
• 72 Launay D, Remy-Jardin M, Michon-Pasturel U. , et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006; 33 (09) 1789-1801
• 73 Fischer A, Swigris JJ, Groshong SD. , et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 2008; 134 (03) 601-605
• 74 Desai SR, Veeraraghavan S, Hansell DM. , et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232 (02) 560-567
• 75 Goldin JG, Kim GHJ, Tseng C-H. , et al. Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II. Ann Am Thorac Soc 2018; 15 (11) 1286-1295
• 76 Silva CIS, Müller NL, Lynch DA. , et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246 (01) 288-297
• 77 Akira M, Inoue Y, Kitaichi M, Yamamoto S, Arai T, Toyokawa K. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251 (01) 271-279
• 78 Chan TY, Hansell DM, Rubens MB, du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 1997; 52 (03) 265-270
• 79 Zhan X, Koelsch T, Montner SM. , et al. Differentiating usual interstitial pneumonia from nonspecific interstitial pneumonia using high-resolution computed tomography: the “Straight-edge Sign”. J Thorac Imaging 2018; 33 (04) 266-270
• 80 Walkoff L, White DB, Chung JH, Asante D, Cox CW. The four corners sign: a specific imaging feature in differentiating systemic sclerosis-related interstitial lung disease from idiopathic pulmonary fibrosis. J Thorac Imaging 2018; 33 (03) 197-203
• 81 de Souza RBC, Borges CTL, Capelozzi VL. , et al. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis. Respiration 2009; 77 (04) 389-397
• 82 Fischer A, Misumi S, Curran-Everett D. , et al. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease. Chest 2007; 131 (04) 988-992
• 83 Bakker ME, Ninaber MK, Stolk J. , et al. Lung density and pulmonary artery diameter are predictors of pulmonary hypertension in systemic sclerosis. J Thorac Imaging 2017; 32 (06) 391-397
• 84 Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest 2006; 130 (04) 976-981
• 85 Stern EJ, Swensen SJ, Hartman TE, Frank MS. CT mosaic pattern of lung attenuation: distinguishing different causes. AJR Am J Roentgenol 1995; 165 (04) 813-816
• 86 Rajaram S, Swift AJ, Condliffe R. , et al. CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax 2015; 70 (04) 382-387
• 87 Tyndall AJ, Bannert B, Vonk M. , et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69 (10) 1809-1815
• 88 Suliman YA, Dobrota R, Huscher D. , et al. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 2015; 67 (12) 3256-3261
• 89 Tashkin DP, Roth MD, Clements PJ. , et al; Sclerodema Lung Study II Investigators. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 2016; 4 (09) 708-719
• 90 Kwon HM, Kang EH, Park JK. , et al. A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford) 2015; 54 (10) 1792-1796
• 91 Hax V, Bredemeier M, Didonet Moro AL. , et al. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis. Semin Arthritis Rheum 2017; 47 (02) 228-234
• 92 Goh NS, Desai SR, Veeraraghavan S. , et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177 (11) 1248-1254
• 93 Champtiaux N, Cottin V, Chassagnon G. , et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: a syndrome associated with heavy morbidity and mortality. Semin Arthritis Rheum 2018; pii: S0049-0172(17)30511-5
• 94 Okamoto M, Fujimoto K, Sadohara J. , et al. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease. Respir Investig 2016; 54 (06) 445-453
• 95 Enomoto Y, Nakamura Y, Colby TV. , et al. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease. PLoS One 2017; 12 (06) e0180283
• 96 Antoniou KM, Margaritopoulos GA, Goh NS. , et al. Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol 2016; 68 (04) 1004-1012
• 97 Gleason JB, Patel KB, Hernandez F. , et al. Pulmonary artery dimensions as a prognosticator of transplant-free survival in scleroderma interstitial lung disease. Hai 2017; 195 (04) 403-409
• 98 Qin B, Wang J, Yang Z. , et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74 (11) 1983-1989
• 99 Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, Moutsopoulos HM. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome. Clin Exp Rheumatol 2018; 36 (3, suppl 112): 94-101
• 100 Soto-Cardenas M-J, Perez-De-Lis M, Bove A. , et al. Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance. Clin Exp Rheumatol 2010; 28 (05) 647-653
• 101 Nakanishi M, Fukuoka J, Tanaka T. , et al. Small airway disease associated with Sjögren's syndrome: clinico-pathological correlations. Respir Med 2011; 105 (12) 1931-1938
• 102 Borie R, Schneider S, Debray M-P. , et al. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Respir Med 2011; 105 (01) 130-136
• 103 Gao H, Zhang X-W, He J. , et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: a case-control study. Medicine (Baltimore) 2018; 97 (24) e11003
• 104 Dong X, Zhou J, Guo X. , et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol 2018; 37 (11) 2981-2988
• 105 Johkoh T, Müller NL, Pickford HA. , et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212 (02) 567-572
• 106 Honda O, Johkoh T, Ichikado K. , et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 1999; 173 (01) 71-74
• 107 Kokosi MA, Nicholson AG, Hansell DM, Wells AU. Rare idiopathic interstitial pneumonias: LIP and PPFE and rare histologic patterns of interstitial pneumonias: AFOP and BPIP. Respirology 2016; 21 (04) 600-614
• 108 Wislez M, Cadranel J, Antoine M. , et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999; 14 (02) 423-429
• 109 Rajagopala S, Singh N, Gupta K, Gupta D. Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature. Respirology 2010; 15 (05) 860-866
• 110 Kobak S, Kalkan S, Kirilmaz B, Orman M, Ercan E. Pulmonary arterial hypertension in patients with primary Sjögren's syndrome. Autoimmune Dis 2014; 2014: 710401
• 111 Sato T, Hatano M, Iwasaki Y. , et al. Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension. PLoS One 2018; 13 (05) e0197297
• 112 Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LTH. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65 (06) 796-803
• 113 Richards TJ, Eggebeen A, Gibson K. , et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009; 60 (07) 2183-2192
• 114 Oikonomou A, Hansell DM. Organizing pneumonia: the many morphological faces. Eur Radiol 2002; 12 (06) 1486-1496
• 115 Hozumi H, Fujisawa T, Nakashima R. , et al. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease. Respir Med 2016; 121: 91-99
• 116 Alqatari S, Riddell P, Harney S, Henry M, Murphy G. MDA-5 associated rapidly progressive interstitial lung disease with recurrent pneumothoraces: a case report. BMC Pulm Med 2018; 18 (01) 59
• 117 Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard J-F. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011; 63 (11) 3439-3447
• 118 Kang EH, Lee EB, Shin KC. , et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005; 44 (10) 1282-1286
• 119 Zamora AC, Hoskote SS, Abascal-Bolado B. , et al. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med 2016; 118: 39-45
• 120 Tanizawa K, Handa T, Nakashima R. , et al. The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 2013; 107 (05) 745-752
• 121 Gunnarsson R, Molberg O, Gilboe I-M, Gran JT. ; PAHNOR1 Study Group. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis 2011; 70 (06) 1047-1051
• 122 Gunnarsson R, Aaløkken TM, Molberg Ø. , et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis 2012; 71 (12) 1966-1972
• 123 Sullivan WD, Hurst DJ, Harmon CE. , et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984; 63 (02) 92-107
• 124 Gunnarsson R, Andreassen AK, Molberg Ø. , et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology (Oxford) 2013; 52 (07) 1208-1213
• 125 Yamanaka Y, Baba T, Hagiwara E. , et al. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis. Eur J Radiol 2018; 107: 26-32
• 126 Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985; 60 (12) 813-821
• 127 Kawano-Dourado L, Baldi BG, Kay FU. , et al. Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years. Clin Exp Rheumatol 2015; 33 (02) 234-240
• 128 Collard HR, Ryerson CJ, Corte TJ. , et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med 2016; 194 (03) 265-275
• 129 Tachikawa R, Tomii K, Ueda H. , et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 2012; 83 (01) 20-27
• 130 Suda T, Kaida Y, Nakamura Y. , et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103 (06) 846-853
• 131 Rice AJ, Wells AU, Bouros D. , et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol 2003; 119 (05) 709-714
• 132 Bhamra K, Stevens R. Pulmonary sarcoidosis following etanercept treatment. Case Rep Rheumatol 2012; 2012: 724013
• 133 Kwon HJ, Coté TR, Cuffe MS, Kramer JM, Braun MM. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003; 138 (10) 807-811
• 134 Rozin A, Yigla M, Guralnik L. , et al. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006; 25 (03) 384-388
• 135 Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009; 68 (07) 1100-1104
• 136 Mori S, Koga Y, Sugimoto M. Organizing pneumonia in rheumatoid arthritis patients: a case-based review. Clin Med Insights Circ Respir Pulm Med 2015; 9 (Suppl. 01) 69-80
• 137 Padley SP, Adler B, Hansell DM, Müller NL. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46 (04) 232-236